Anabel Torrente-López, Jesús Hermosilla, Antonio Salmerón-García, José Cabeza, & Natalia Navas. (2022). Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. MDPI AG.
Chicago Style (17th ed.) CitationAnabel Torrente-López, Jesús Hermosilla, Antonio Salmerón-García, José Cabeza, and Natalia Navas. Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. MDPI AG, 2022.
MLA (9th ed.) CitationAnabel Torrente-López, et al. Comprehensive Analysis of Nivolumab, A Therapeutic Anti-Pd-1 Monoclonal Antibody: Impact of Handling and Stress. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.